Navigation Links
Breaking Boundaries Program Honors Colorectal Cancer Survivors for Outstanding Leadership Achievements
Date:3/11/2008

to all; and for increased awareness that colorectal cancer is preventable, treatable, and beatable.


'/>"/>
SOURCE Colorectal Cancer Coalition (C3)
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. CEL-SCI CORPORATION Announces Results of 2008 Annual Meeting of Shareholders and Provides Update on Ground-breaking Activities Regarding Construction of Manufacturing Facility for Pivotal Phase III Cancer Trial
2. Groundbreaking Sign Chi Do Stress Management System Introduced by Dr. Anne Borik Now Available to the Public
3. Representative Greg Harris, Senator Jacqueline Collins, Senator Iris Martinez and Fellow State Legislators to Join Susan G. Komen for the Cure in Announcing Groundbreaking Legislation to Reduce Breast Cancer Disparities; Will Hold Press Conference Friday
4. Loma Linda University Medical Center Celebrates Groundbreaking on Inland Empires Most Comprehensive Rehabilitation Center
5. Aware, Inc. to Demonstrate Groundbreaking Medical Imaging Streaming Solution at HIMSS08
6. Breaking Down Barriers: A Womans Path to Reducing HIV Stigma in the Arab American Community
7. Groundbreaking Deloitte Survey Reveals Many U.S. Consumers Want Major Changes in Health Care Design, Delivery
8. CleanRest(R) Announces a Groundbreaking Invention, The Worlds Cleanest Pillow(TM)
9. Orqis(R) Medicals MOMENTUM Trial Abstract Accepted for Late Breaking Clinical Trial Presentation at the American College of Cardiology Annual Meeting
10. Breaking down Huntingtons disease one protein at a time
11. California Institute of Integral Studies Launches Groundbreaking Community Mental Health Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/5/2008)...ert Pathologists Discuss the Latest Developments i...RTHFIELD, Ill., Sept. 5 /PRNewswire-USNewswire/ --...point. Molecular testing and the promise,of person...reated. Digital,slides and other imaging technolog...lege of American Pathologists is taking a leadersh...
(Date:9/5/2008)...hers explain how theoretical ,anti-cloak, could br...pt. 5 (HealthDay News) -- Just in case someone dev...cientists say they know how to uncloak the objects... Optics Express , certain materials underneath an ...o be seen again. , Researchers at Shanghai Jiao...
(Date:9/5/2008)...HINGTON, Sept. 5 /PRNewswire-USNewswire/ -- Speake...y in support of the aims of the "Stand,Up to Cance... "There is not a person in our country who has no...r kills 565,000 Americans annually, and each,year ...ricans must work,together to make eradicating the ...
(Date:9/5/2008)...HINGTON, Sept. 5 /PRNewswire-USNewswire/ -- U.S. c...r relief to Cuban victims of Hurricane,Gustav, whi...s., (http://www.PanAmericanRelief.org ), "Donatio...perately need,after this natural disaster," says M... Initiative at the Pan American Development Founda...
Breaking Medicine News(10 mins):Health News:Leaders in Pathology Meet in San Diego: Sept. 25 - 28, 2008 2Health News:Cuban Disaster Relief Donations Sought in the Wake of Hurricane Gustav 2
... Service for Wales (NPHS) has announced that the a...ry rare after a caseworker was apparently diagnose...00 patients in Gwynedd are to be screened for the ... risk to patients and is preparing a comprehensive...
...remier retail chain of coffee cafes, on opening it... has planned to reach the target of 500 by the yea...re very happy to have played a large role in firml... in our country," said Naresh Malhotra, director o...
...the activation of which is associated with cancer ...mal functioning of the immune system, according to...pecifically, c-myc has been found to be important ...vious infections. In order to rapidly and efficie...
...e Institute of Neurological Disease have now prove...ersial protein, apolipoprotein E, is indeed produc...r the first time established a definitive associat...oE, this cholesterol-carrying protein has three co...
Other Medicine News:Health News:Alzheimer's-linked apolipoprotein E produced by neurons, Gladstone study 2
(Date:9/4/2008)...ication for Targeted Therapies That E...GTON BEACH, Calif., and AMSTERDAM, Netherlands, Se...olecular cancer diagnostics,today announced the l...t,allows physicians to quantitatively determine th...(ER), progesterone receptor (PR) and Human Epiderm...
(Date:9/3/2008)... Research and Education Foundation,s Within Our R...ting, Treating and Understandi...irst time during its,unprecedented initiative to f...College of Rheumatology Research and Education Fou... research funded by the Within Our,Reach: Finding ...
(Date:9/3/2008)...(dronedarone) decreased the risk of,stroke by 34% ...ter already adequately treated by ant...- The results of a,post-hoc...resented today at,the clinical trial update sessio...008, in Munich, Germany. Previous results from the...
(Date:9/3/2008)...re-FirstCall/ -- A sub-analysis of,the TRITON-TIMI...ugrel,compared with clopidogrel significantly redu...4 percent vs. 9.7 percent, p<0.0001), regardless,o...n artery-opening,procedure known as percutaneous c...ontaneously during the longer-term maintenance pha...
Breaking Medicine Technology:Agendia Launches TargetPrint(R) for Breast Cancer Patients 2New Research Shows Promise for Finding A Cure for Rheumatoid Arthritis 2New Research Shows Promise for Finding A Cure for Rheumatoid Arthritis 3Further Analysis From ATHENA Study Showed That Multaq(R) (dronedarone) Reduced the Risk of Stroke in Patients With Atrial Fibrillation 2Further Analysis From ATHENA Study Showed That Multaq(R) (dronedarone) Reduced the Risk of Stroke in Patients With Atrial Fibrillation 3Further Analysis From ATHENA Study Showed That Multaq(R) (dronedarone) Reduced the Risk of Stroke in Patients With Atrial Fibrillation 4Further Analysis From ATHENA Study Showed That Multaq(R) (dronedarone) Reduced the Risk of Stroke in Patients With Atrial Fibrillation 5Prasugrel Significantly Reduced New or Recurrent Heart Attacks in Both Acute and Longer-Term Settings Following PCI, Compared with Clopidogrel 2Prasugrel Significantly Reduced New or Recurrent Heart Attacks in Both Acute and Longer-Term Settings Following PCI, Compared with Clopidogrel 3Prasugrel Significantly Reduced New or Recurrent Heart Attacks in Both Acute and Longer-Term Settings Following PCI, Compared with Clopidogrel 4Prasugrel Significantly Reduced New or Recurrent Heart Attacks in Both Acute and Longer-Term Settings Following PCI, Compared with Clopidogrel 5Prasugrel Significantly Reduced New or Recurrent Heart Attacks in Both Acute and Longer-Term Settings Following PCI, Compared with Clopidogrel 6New chemotherapy combo produces side effects but no extra efficacy in early breast cancer patients 2933 1New chemotherapy combo produces side effects but no extra efficacy in early breast cancer patients 2933 2Vobile Launches VideoDNA Live 3B Enables Real Time Digital Content Protection for Live Broadcast Events 2931 1Vobile Launches VideoDNA Live 3B Enables Real Time Digital Content Protection for Live Broadcast Events 2931 2Vobile Launches VideoDNA Live 3B Enables Real Time Digital Content Protection for Live Broadcast Events 2931 3Young Boy With Epilepsy to Gain Independence With New Seizure Response Dog From Canine Assistants 17058 1Young Boy With Epilepsy to Gain Independence With New Seizure Response Dog From Canine Assistants 17058 2Womens Sports Foundation Hosted The Billies Recognizing Media Excellence in Womens Sports and Physical Activity 17053 1Womens Sports Foundation Hosted The Billies Recognizing Media Excellence in Womens Sports and Physical Activity 17053 2Womens Sports Foundation Hosted The Billies Recognizing Media Excellence in Womens Sports and Physical Activity 17053 3
...swire/ -- Phase 3 results,from the RE-NOVATE(TM) t...nce daily, administered for an average of 33 days,... for an average of 33,days, in preventing venous t... total hip replacement surgery. In this trial, the... etexilate was,similar to enoxaparin. The incidenc...
...2007 - The Journal of the,American Society of Clin... clinical study conducted by Dr. Siu-Fun Wong, and...gel, Regenecare(R),caused a statistically signifi...hat results from the use of anti-cancer drugs,know... trial is,listed on the National Cancer Institute ...
Other Medicine Technology:Phase 3 Results for Dabigatran Etexilate, an Investigational Oral,Anticoagulant, Presented Today at the XXIst Congress of the,International Society on Thrombosis and Haemostasis 2Phase 3 Results for Dabigatran Etexilate, an Investigational Oral,Anticoagulant, Presented Today at the XXIst Congress of the,International Society on Thrombosis and Haemostasis 3Phase 3 Results for Dabigatran Etexilate, an Investigational Oral,Anticoagulant, Presented Today at the XXIst Congress of the,International Society on Thrombosis and Haemostasis 4Phase 3 Results for Dabigatran Etexilate, an Investigational Oral,Anticoagulant, Presented Today at the XXIst Congress of the,International Society on Thrombosis and Haemostasis 5Clinical Study Shows Regenecare Relieves Pain and Itching of Skin,Rashes Caused by Widely Used Cancer Drugs 2
Tennant straight tying forceps with extra delicate smooth jaws, 6 mm tying platform, For 9-0 to 11-0 sutures. Overall length 108 mm.
Kelman - McPherson angled tying forceps is long with tying platform 10 mm, serrated handle and polished finish.
Castroviejo tying forceps, straight.
Gerl titanium tying forceps has curved shanks, smooth jaws and 6 mm long tying platform. For 8-0 to 11-0 sutures.
Medicine Products: